MyStocks

MEMBER'S LOGINX

Remember Username
Keep me signed in

(Please do not use this option on a public machine)

Print
Text -Size
RSS
FaceBook
Twitter
Linked In
WhatsApp

Home
Todays Market
Indian Stock Market Updates June 12, 2018

GLENMARK PHARMA surges by 5%; BSE HEALTHCARE Index Up 2.2%
Tue, 12 Jun 12:56 PM

GLENMARK PHARMA share price has Zoomed 5% and is presently trading at Rs 596.

Meanwhile, the BSE HEALTHCARE Index is at 13,794 (Up 2.2%).

Among the top Gainers in the BSE HEALTHCARE Index today are GLENMARK PHARMA (up 5.49%) and LUPIN LTD (up 5.62%).

SHILPA MEDICARE (down 0.05%) and LAURUS LABS LTD (down 0.09%) are among the top losers today.

Over the last one year, GLENMARK PHARMA has moved down from Rs 637 to Rs 596, registering a loss of Rs 42 (down 6.51%)

On the other hand, the BSE HEALTHCARE has moved down from 14,264 to 13,794, loss of 470 points (down 3.35%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were BIOCON LTD (up 79.41%), DIVIS LABORATORIES (up 63.86%) and PFIZER (up 57.06%).

Access Now: Eight Steps to Your Eight Figure Fortune

What About the Benchmark Indices?

The BSE Sensex is at 35,726 (up 0.57%).

The top gainers among the BSE Sensex stocks today are DR. REDDYS LAB (up 4.67%), SBI (up 2.21%) and TCS (up 1.51%). Other gainers include SUN PHARMA (up 1.42%) and INDUSIND BANK (up 1.34%). The most traded stocks in the BSE Sensex are ADANI PORTS & SEZ and SBI.

In the meantime, NSE Nifty is at 10,856 (up 0.42%). LUPIN LTD (up 5.13%) and SBI (up 2.03%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 31,096 to 35,726, registering a gain of 4,630 points (up 14.76%).

GLENMARK PHARMA Financial Update...

GLENMARK PHARMA net profit grew 44.8% YoY to Rs 2 billion for the quarter ended March 2018, compared to a profit of Rs 1 billion a year ago. Net Sales rose 103.5% to Rs 22.8 billion during the period as against Rs 22.0 billion in January-March 2017.

For the year ended March 2017, GLENMARK PHARMA reported 60.1% increase in net profit to Rs 11.9 billion compared to net profit of Rs 7.4 billion during FY16.

Revenue of the company grew 20.1% to Rs 92 billion during FY17.

The current Price to earnings ratio of GLENMARK PHARMA, based on rolling 12 month earnings, stands at 20.9x.

Stock Market Updates

Sensex Zooms 1,030 Points, Nifty Tops 14,980-Mark; HDFC Bank Among Top Gainers (Today's Market)

Feb 24, 2021 Closing

Indian share markets witnessed huge buying interest during the extended closing hours today and ended their day on a strong note.

Sensex Rises 477 Points; Trading Resumes on NSE (Today's Market)

Feb 24, 2021 Special Update

The BSE Sensex is trading up by 477 points, while the NSE Nifty is trading up by 135 points.

SIEMENS at All Time High; BSE CAPITAL GOODS Index Up 0.5% (Today's Market)

Feb 24, 2021 02:54 PM

SIEMENS share price has hit an all time high at Rs 1,922 (up 1.7%). The BSE CAPITAL GOODS Index is up by 0.5%. Among the top gainers in the BSE CAPITAL GOODS Index today are SIEMENS (up 1.7%) and HONEYWELL AUTOMATION (up 1.9%). The top losers include HAVELLS INDIA (down 0.2%) and GRAPHITE INDIA (down 0.2%).

MUTHOOT FINANCE Share Price Down by 6%; BSE 500 Index Up 0.5% (Today's Market)

Feb 24, 2021 02:36 PM

MUTHOOT FINANCE share price is trading down by 6% and its current market price is Rs 1,315. The BSE 500 is up by 0.5%. The top gainers in the BSE 500 Index are INDIAN OVERSEAS BANK (up 10.0%) and BANK OF MAHARASHTRA (up 10.0%). The top losers are MUTHOOT FINANCE (down 5.8%) and HIMADRI SPECIALITY CHEMICAL (down 5.4%).

ZENSAR TECHNOLOGIES at 52 Week High; BSE 500 Index Up 1.0% (Today's Market)

Feb 24, 2021 01:02 PM

ZENSAR TECHNOLOGIES share price has hit a 52-week high. It is presently trading at Rs 282. BSE 500 Index is up by 0.5% at 19,684. Within the BSE 500, ZENSAR TECHNOLOGIES (up 5.3%) and NAVA BHARAT VENTURES (up 11.2%) are among the top gainers, while top losers are MAGMA FINCORP and RELIANCE POWER.

Sensex Trades Over 200 Points Higher; Dow Futures Down by 103 Points (Today's Market)

Feb 24, 2021 12:30 pm

BSE Sensex is trading up by 226 points, while the NSE Nifty is trading up by 113 points.

View More Indian Share Market News

S&P BSE SENSEX

50,781.69 2.07%
Feb 24, 2021 (Close)

FEATURED VIDEOS

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

Nasdaq & Nifty Could Reverse

Don't Fall for the 'Best Sector of 2021' Story

MARKET STATS

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS

PREMIUM PRODUCTS

QUICK LINKS

FOLLOW

APP

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

MEMBER'S LOGINX

GLENMARK PHARMA surges by 5%; BSE HEALTHCARE Index Up 2.2% Tue, 12 Jun 12:56 PM

What About the Benchmark Indices?

GLENMARK PHARMA Financial Update...

Indian Share Market Update: Top Gainers and Losers

Stock Market Updates

Sensex Zooms 1,030 Points, Nifty Tops 14,980-Mark; HDFC Bank Among Top Gainers (Today's Market)

Sensex Rises 477 Points; Trading Resumes on NSE (Today's Market)

SIEMENS at All Time High; BSE CAPITAL GOODS Index Up 0.5% (Today's Market)

MUTHOOT FINANCE Share Price Down by 6%; BSE 500 Index Up 0.5% (Today's Market)

ZENSAR TECHNOLOGIES at 52 Week High; BSE 500 Index Up 1.0% (Today's Market)

Sensex Trades Over 200 Points Higher; Dow Futures Down by 103 Points (Today's Market)

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Penny Stock Master Series: The Quest for 10X Profits in 10 Years(Profit Hunter)

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

OUR TOP 5 IDEAS